Buscar
01/07/2025
Analytical Interference of Exemestane with Androstenedione Immunoassays
Giralt, M, Ferrer, R, Díaz-Troyano, N, Vega, B, Luque-Ramírez, M, Martínez, S, Fernández, B, Martínez, I, Fabregat, A, Urgell, E, Cardona, I, Casals, G, Escobar-Morreale, HF. Analytical Interference of Exemestane with Androstenedione Immunoassays. Annals of Laboratory Medicine. 2025; 45(4)DOI:10.3343/alm.2024.0362. PMID:40114653. IF:3.900(Q1/1D).
01/09/2024
Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis
Fernandez-Bravo, S, Canyelles, M, Martín-Blázquez, A, Borràs, C, Nuñez-Borque, E, Palacio-García, L, Del Rio, PR, Betancor, D, Gómez-López, A, Brescó, MS, Laguna, JJ, Méndez-Barbero, N, Rotllan, N, Escolà-Gil, JC, Esteban, V. Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2024; 154(3)DOI:10.1016/j.jaci.2024.03.031. PMID:38718948. IF:11.200(Q1/1D).
01/08/2024
IN VITRO AND IN VIVO EFFECTS OF LIVER X RECEPTOR AND CHOLESTEROL LOADING IN VASCULAR SMOOTH MUSCULAR CELL-SPECIFIC REVERSE CHOLESTEROL TRANSPORT
Velasco, L, Querol, CB, Santos, D, Rotllan, N, Tondo, M, Camacho, M, Blanco-Vaca, F, Escolà-Gil, JC, Canyelles, M. IN VITRO AND IN VIVO EFFECTS OF LIVER X RECEPTOR AND CHOLESTEROL LOADING IN VASCULAR SMOOTH MUSCULAR CELL-SPECIFIC REVERSE CHOLESTEROL TRANSPORT. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
01/08/2024
HDL PROTEOME ASSOCIATES WITH HEPATIC AND ADIPOSE TISSUE INSULIN RESISTANCE AND CHOLESTEROL EFFLUX CAPACITY IN METABOLIC SYNDROME PATIENTS
Grao-Cruces, E, Mocciaro, G, Marquez-Paradas, E, Santos-Mejias, A, Canyelles, M, Escola-Gil, JC, Martin-Rubio, ME, La Paz, SMD. HDL PROTEOME ASSOCIATES WITH HEPATIC AND ADIPOSE TISSUE INSULIN RESISTANCE AND CHOLESTEROL EFFLUX CAPACITY IN METABOLIC SYNDROME PATIENTS. ATHEROSCLEROSIS. 2024; 395DOI:. PMID:. IF:5.700(Q1/1D).
31/07/2024
Improvement of non-adherence and reduction of BP values in patients with difficult-to-treat hypertension: the ATHAN clinical trial
Oliveras, A, Vázquez, S, Vega, MV, Camps, C, Illana, FJ, Armario, P, Crespo, M, de la Sierra, A. Improvement of non-adherence and reduction of BP values in patients with difficult-to-treat hypertension: the ATHAN clinical trial. HYPERTENSION RESEARCH. 2024; DOI:10.1038/s41440-024-01748-x. PMID:39085464. IF:4.600(Q1/2D).
01/07/2024
Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice
Delgado-Lista, J, Mostaza, JM, Arrobas-Velilla, T, Blanco-Vaca, F, Masana, L, Pedro-Botet, J, Perez-Martinez, P, Civeira, F, Cuende-Melero, JI, Gomez-Barrado, JJ, Lahoz, C, Pinto, X, Suarez-Tembra, M, Lopez-Miranda, J, Guijarro, C. Consensus on lipoprotein(a) of the Spanish Society of Arteriosclerosis. Literature review and recommendations for clinical practice. Clinica E Investigacion En Arteriosclerosis. 2024; 36(4)DOI:10.1016/j.arteri.2024.03.002. PMID:38599943. IF:(Q/D).
17/06/2024
Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis
La Lhoëst, MTL, Martinez, A, Claudi, L, Garcia, E, Benitez-Amaro, A, Polishchuk, A, Piñero, J, Vilades, D, Guerra, JM, Sanz, F, Rotllan, N, Escolà-Gil, JC, Llorente-Cortés, V. Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis. Frontiers in Cardiovascular Medicine. 2024; 11DOI:10.3389/fcvm.2024.1381520. PMID:38952543. IF:2.900(Q2/4D).
01/06/2024
Apolipoproteins and Lipoproteins in Health and Disease 2.0
Rotllan, N, Escolà-Gil, JC. Apolipoproteins and Lipoproteins in Health and Disease 2.0. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(11)DOI:10.3390/ijms25116183. PMID:38892369. IF:4.900(Q1/3D).